MEDICLINIC INTERNATIONAL PLC

Director's Dealing • Nov 23, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3900X

Mediclinic International plc

23 November 2017

Mediclinic International PLC

(Incorporated in England and Wales)

Company Number: 08338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

("Mediclinic" or the "Company")

23 November 2017

Purchase of shares in Mediclinic by Jurgens Myburgh, Chief Financial Officer

On 21 November 2017, Jurgens Myburgh, Chief Financial Officer, acquired 30,000 shares in the Company at ZAR 100.70 per share. Accordingly, Mr Myburgh now owns a total of 60,000 shares in Mediclinic International plc. 

The following notification is made in accordance with Articles 19.1 and 19.3 of the Market Abuse Regulation.

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Petrus Jurgens Myburgh

2.

Reason for the notification

a)

Position / status

Chief Financial Officer of the Company

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

b)

LEI

2138002S5BSBIZTD5I60

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares

GB00B8HX8Z88

b)

Nature of the transaction

Purchase of shares 

c)

Price(s) and volume(s)

Prices (ZAR)	Volumes
100.70	30,000

d)

Aggregated information

Aggregated volume

Price

30,000

ZAR 100.70 per share

e)

Date of the transaction

21 November 2017; 08:00 UTC

f)

Place of the transaction

Johannesburg Stock Exchange

About Mediclinic International plc

Mediclinic is an international private healthcare group with operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a LSE listed and UK-based private healthcare group.

Mediclinic comprises 75 hospitals and 29 clinics. Mediclinic Southern Africa operates 49 hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8 000 inpatient beds in total; Hirslanden operates 17 private acute care facilities and 4 clinics in Switzerland with more than 1 700 inpatient beds; and Mediclinic Middle East operates 6 hospitals and 23 clinics with more than 700 inpatient beds in the United Arab Emirates.

During February 2016, the combination of the Company (previously named Al Noor Hospitals Group plc), with operations mainly in Abu Dhabi in the United Arab Emirates, and Mediclinic International Limited was completed. Mediclinic International Limited was a South African based international private healthcare group founded in 1983 and listed on the JSE, the South African stock exchange, since 1986, with operations in South Africa, Namibia, Switzerland and the United Arab Emirates (mainly in Dubai). The combination resulted in the renaming of the enlarged group to Mediclinic International plc.

Mediclinic has a primary listing on the Main Market of the LSE, with secondary listings on the JSE in South Africa and the NSX in Namibia.

For further information, please contact:

Link Company Matters Limited

Victoria Dalby / Caroline Emmet

+44 (0)20 7954 9600

Investor Relations, Mediclinic International plc

James Arnold, Head of Investor Relations

ir@mediclinic.com  

+44 (0)20 3786 8181

Media queries

FTI Consulting

Brett Pollard / Debbie Scott (UK)

+44 (0)20 3727 1000

Frank Ford (South Africa)

+27 (0)21 487 9000

Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom  

Website: www.mediclinic.com

Corporate broker: Morgan Stanley & Co International plc

JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBSBDBDUDBGRX